A memo from the NIH's acting director indicated research and clinical studies that began prior to Trump's inauguration can ...
As the Trump administration issued an abrupt pause to federal financial assistance, the move threatened billions in grants ...
Pharmaron, a Chinese biotech firm, is currently using hundreds of thousands of taxpayer dollars to test pharmaceuticals on up ...
Just days after President Trump imposed broad restrictions on communications, meetings, travel and public appearances at the ...
"We need to know what adverse events are. We need to understand the safety of every drug, mifepristone, and every other drug.
The agency expects “additional guidance” this week on the communications freeze — which unleashed confusion about whether ...
An unprecedented federal ban on scientific meetings halts research progress, sparking widespread concern across the ...
The University of Nebraska said it was waiting for more information about what a pause in activities at the National ...
Major academic research institutions and medical schools in the Philadelphia region are allotted $1.7 billion in NIH funding.
Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory ...
At NIH, Memoli heads the Laboratory of Infectious Disease (LID) Clinical Studies Unit (CSU), where much of the research has ...